Recalls / Firms / Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

12 FDA drug recalls on record.

Date	Class	Drug	Status
2023-03-09	Class II	Jardiance	Terminated
2021-05-04	Class II	Micardis	Terminated
2020-10-05	Class II	Catapres (clonidine hydrochloride, USP) 0.2 mg, tablet, 100-count bottle, Rx only, Dist.	Terminated
2020-10-05	Class II	Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist.	Terminated
2020-10-05	Class II	Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet, 100-count bottle, Rx only, Dist.	Terminated
2019-03-07	Class III	Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per foldi	Terminated
2018-10-22	Class II	Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Bo	Terminated
2018-09-04	Class II	Synjardy	Terminated
2017-12-14	Class II	Spiriva	Terminated
2017-09-22	Class III	Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehring	Terminated
2016-10-06	Class II	DIPYRIDAMOLE Tablets USP, 75 mg, 100-count bottle, Rx only, Dist. by: Roxane Laboratories,	Terminated
2016-10-06	Class II	Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehri	Terminated